Position in DXCM
as of Mar 31, 2026
· filed May 11, 2026
Position Value
$368,950
-$16,659 QoQ
Shares Held
5,875
+1.1% QoQ
Ownership
0.002%
of shares outstanding
% of Portfolio
0.07%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Mar 2025
4 quarters on record
Voting authority
Sole 0.ToString("F0")%
Shared 0.ToString("F0")%
None 100.ToString("F0")%
Common Shares in DXCM Over Time
Shares Held
Position Value (USD)
Position in Medical Devices
Healthcare · as of Mar 31, 2026Sargent Investment Group, LLC holds $6,205,842 across 8 Medical Devices names. DXCM ranks #4 (5.9% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | ABT |
Abbott Laboratories
|
30,277 | $3,108,539 | |
| 2 | MDT |
Medtronic plc
|
15,782 | $1,367,510 | |
| 3 | PODD |
Insulet Corp
|
2,363 | $495,851 | |
| 4 | DXCM |
Dexcom Inc
This page
|
5,875 | $368,950 | |
| 5 | CTSO |
Cytosorbents Corp
|
549,900 | $311,243 | |
| 6 | SYK |
Stryker Corp
|
775 | $254,657 | |
| 7 | GEHC |
GE HealthCare Technologies Inc.
|
3,329 | $236,958 | |
| 8 | LUCD |
Lucid Diagnostics Inc.
|
54,030 | $62,134 |
All Filings in DXCM
Export CSV
4 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $368,950 | 5,875 | Shares | Sole | 2026-05-11 | |
| 2025-12-31 | $385,609 | 5,810 | Shares | Sole | 2026-02-13 | |
| 2025-06-30 | $1,033,077 | 11,835 | Shares | Sole | 2025-08-14 | |
| 2025-03-31 | $905,866 | 13,265 | Shares | Sole | 2025-05-05 | |
| No filing history on record for this holder in this stock. | ||||||